Log In
BCIQ
Print this Print this
 

crenolanib besylate (ARO-002) (formerly CP-868596, plarotinib)

Also known as: formerly CP-868,596

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSmall molecule inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135), platelet derived growth factor receptor A (PDGFRA; PDGFR2; CD140A) and PDGFRB
Molecular Target FMS-like tyrosine kinase 3 (FLT3) (CD135) ; Platelet derived growth factor receptor (PDGFR)
Mechanism of ActionPlatelet derived growth factor receptor A (PDGFRA) inhibitor; Platelet derived growth factor receptor B (PDGFRB) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/31/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today